Expert Opinion on Drug Discovery

Expert Opin Drug Discov

1746-0441

1746-045X

Therapeutic Area

Pharmacology, Rare Diseases

Academics, Biomedical Researchers, Clinical Pharmacologists, Clinicians, Industrial Scientists, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Scientists

Expert Opinion on Drug Discovery (1746-0441; 1746-045X) is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles in drug discovery. Expert Opinion on Drug Discovery publishes original research and review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimization at the preclinical level. Articles focus on the following key areas: Chemoinformatics; Bioinformatics; Assay development; Novel screening technologies; In vitro/in vivo models; Structure-based drug design; Systems biology. The journal also publishes drug case histories examining the steps involved in the preclinical and clinical development of a particular drug.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines